Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab https://t.co/rbhQqdc9rq https://t.co/AyWZtJABdD
2,887 followers
2,887 followers
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports https://t.co/3D39mVqyjv
81 followers
Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports https://t.co/LInPmeXaxV
906 followers
New article: Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports https://t.co/DKB1qgJHFC #lungcancer #oncology https://t.co/4KrRNa2x1R